Monoallelic and Biallelic Mutations in MAB21L2 Cause a Spectrum of Major Eye Malformations
2014; Elsevier BV; Volume: 94; Issue: 6 Linguagem: Inglês
10.1016/j.ajhg.2014.05.005
ISSN1537-6605
AutoresJoe Rainger, Davut Pehli̇van, Stefan Johansson, Hemant Bengani, Luis Sánchez‐Pulido, Kathleen A. Williamson, Mehmet Türe, Heather Barker, Karen Rosendahl, Jürgen W. Spranger, Denise Horn, Alison Meynert, James Floyd, Trine Prescott, Carl A. Anderson, Jacqueline K. Rainger, Ender Karaca, Claudia Gonzaga‐Jauregui, Shalini N. Jhangiani, Donna M. Muzny, Anne Seawright, Dinesh C. Soares, Mira Kharbanda, Victoria Murday, Andrew J. Finch, Richard A. Gibbs, Veronica van Heyningen, Martin S. Taylor, Tahsin Yakut, Per M. Knappskog, Matthew E. Hurles, Chris P. Ponting, James R. Lupski, Gunnar Houge, David Fitzpatrick, Matthew E. Hurles, David Fitzpatrick, Saeed Al-Turki, Carl A. Anderson, Inês Barroso, Philip L. Beales, Jamie Bentham, Shoumo Bhattacharya, Keren Carss, Krishna Chatterjee, Sebhattin Cirak, Catherine Cosgrove, Allan Daly, Jamie Floyd, Chris Franklin, Marta Futema, Steve E. Humphries, Shane McCarthy, Hannah M. Mitchison, Francesco Muntoni, Alexandros Onoufriadis, Victoria Parker, Felicity Payne, Vincent Plagnol, Lucy Raymond, David B. Savage, Peter Scambler, Miriam Schmidts, Robert K. Semple, Eva Serra, Jim Stalker, Margriet van Kogelenberg, Parthiban Vijayarangakannan, Klaudia Walter, G Black Wood,
Tópico(s)Congenital Ear and Nasal Anomalies
ResumoWe identified four different missense mutations in the single-exon gene MAB21L2 in eight individuals with bilateral eye malformations from five unrelated families via three independent exome sequencing projects. Three mutational events altered the same amino acid (Arg51), and two were identical de novo mutations (c.151C>T [p.Arg51Cys]) in unrelated children with bilateral anophthalmia, intellectual disability, and rhizomelic skeletal dysplasia. c.152G>A (p.Arg51His) segregated with autosomal-dominant bilateral colobomatous microphthalmia in a large multiplex family. The fourth heterozygous mutation (c.145G>A [p.Glu49Lys]) affected an amino acid within two residues of Arg51 in an adult male with bilateral colobomata. In a fifth family, a homozygous mutation (c.740G>A [p.Arg247Gln]) altering a different region of the protein was identified in two male siblings with bilateral retinal colobomata. In mouse embryos, Mab21l2 showed strong expression in the developing eye, pharyngeal arches, and limb bud. As predicted by structural homology, wild-type MAB21L2 bound single-stranded RNA, whereas this activity was lost in all altered forms of the protein. MAB21L2 had no detectable nucleotidyltransferase activity in vitro, and its function remains unknown. Induced expression of wild-type MAB21L2 in human embryonic kidney 293 cells increased phospho-ERK (pERK1/2) signaling. Compared to the wild-type and p.Arg247Gln proteins, the proteins with the Glu49 and Arg51 variants had increased stability. Abnormal persistence of pERK1/2 signaling in MAB21L2-expressing cells during development is a plausible pathogenic mechanism for the heterozygous mutations. The phenotype associated with the homozygous mutation might be a consequence of complete loss of MAB21L2 RNA binding, although the cellular function of this interaction remains unknown. We identified four different missense mutations in the single-exon gene MAB21L2 in eight individuals with bilateral eye malformations from five unrelated families via three independent exome sequencing projects. Three mutational events altered the same amino acid (Arg51), and two were identical de novo mutations (c.151C>T [p.Arg51Cys]) in unrelated children with bilateral anophthalmia, intellectual disability, and rhizomelic skeletal dysplasia. c.152G>A (p.Arg51His) segregated with autosomal-dominant bilateral colobomatous microphthalmia in a large multiplex family. The fourth heterozygous mutation (c.145G>A [p.Glu49Lys]) affected an amino acid within two residues of Arg51 in an adult male with bilateral colobomata. In a fifth family, a homozygous mutation (c.740G>A [p.Arg247Gln]) altering a different region of the protein was identified in two male siblings with bilateral retinal colobomata. In mouse embryos, Mab21l2 showed strong expression in the developing eye, pharyngeal arches, and limb bud. As predicted by structural homology, wild-type MAB21L2 bound single-stranded RNA, whereas this activity was lost in all altered forms of the protein. MAB21L2 had no detectable nucleotidyltransferase activity in vitro, and its function remains unknown. Induced expression of wild-type MAB21L2 in human embryonic kidney 293 cells increased phospho-ERK (pERK1/2) signaling. Compared to the wild-type and p.Arg247Gln proteins, the proteins with the Glu49 and Arg51 variants had increased stability. Abnormal persistence of pERK1/2 signaling in MAB21L2-expressing cells during development is a plausible pathogenic mechanism for the heterozygous mutations. The phenotype associated with the homozygous mutation might be a consequence of complete loss of MAB21L2 RNA binding, although the cellular function of this interaction remains unknown. Structural eye malformations are an important cause of congenital visual impairment.1Haddad M.A. Sei M. Sampaio M.W. Kara-José N. Causes of visual impairment in children: a study of 3,210 cases.J. Pediatr. Ophthalmol. Strabismus. 2007; 44: 232-240PubMed Google Scholar, 2Rudanko S.L. Laatikainen L. Visual impairment in children born at full term from 1972 through 1989 in Finland.Ophthalmology. 2004; 111: 2307-2312Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar The terms anophthalmia and microphthalmia are used to indicate the absence or marked reduction in size, respectively, of an eye. Ocular coloboma (MIM 216820) describes the spectrum of eye malformations, including microphthalmia, resulting from failure of optic fissure closure during embryogenesis. These malformations show marked phenotypic and etiological heterogeneity. The most common identifiable genetic causes of structural eye malformations are those involving dosage-sensitive transcription factors (encoded by SOX2 [MIM 184429],3Fantes J. Ragge N.K. Lynch S.A. McGill N.I. Collin J.R. Howard-Peebles P.N. Hayward C. Vivian A.J. Williamson K. van Heyningen V. FitzPatrick D.R. Mutations in SOX2 cause anophthalmia.Nat. Genet. 2003; 33: 461-463Crossref PubMed Scopus (428) Google Scholar, 4Ragge N.K. Lorenz B. Schneider A. Bushby K. de Sanctis L. de Sanctis U. Salt A. Collin J.R. Vivian A.J. Free S.L. et al.SOX2 anophthalmia syndrome.Am. J. Med. Genet. A. 2005; 135 (discussion 8): 1-7Crossref PubMed Scopus (181) Google Scholar OTX2 [MIM 600037],5Ragge N.K. Brown A.G. Poloschek C.M. Lorenz B. Henderson R.A. Clarke M.P. Russell-Eggitt I. Fielder A. Gerrelli D. Martinez-Barbera J.P. et al.Heterozygous mutations of OTX2 cause severe ocular malformations.Am. J. Hum. Genet. 2005; 76: 1008-1022Abstract Full Text Full Text PDF PubMed Scopus (250) Google Scholar and PAX6 [MIM 607108]6Glaser T. Jepeal L. Edwards J.G. Young S.R. Favor J. Maas R.L. PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.Nat. Genet. 1994; 7: 463-471Crossref PubMed Scopus (598) Google Scholar) and retinoic acid metabolism or transport (regulated by STRA6 [MIM 610745],7Pasutto F. Sticht H. Hammersen G. Gillessen-Kaesbach G. Fitzpatrick D.R. Nürnberg G. Brasch F. Schirmer-Zimmermann H. Tolmie J.L. Chitayat D. et al.Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation.Am. J. Hum. Genet. 2007; 80: 550-560Abstract Full Text Full Text PDF PubMed Scopus (273) Google Scholar ALDH1A3 [MIM 600463],8Fares-Taie L. Gerber S. Chassaing N. Clayton-Smith J. Hanein S. Silva E. Serey M. Serre V. Gérard X. Baumann C. et al.ALDH1A3 mutations cause recessive anophthalmia and microphthalmia.Am. J. Hum. Genet. 2013; 92: 265-270Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar RARB [MIM 180220]9Srour M. Chitayat D. Caron V. Chassaing N. Bitoun P. Patry L. Cordier M.P. Capo-Chichi J.M. Francannet C. Calvas P. et al.Recessive and dominant mutations in retinoic acid receptor beta in cases with microphthalmia and diaphragmatic hernia.Am. J. Hum. Genet. 2013; 93: 765-772Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar). The cause in a significant proportion of individuals with major eye malformations, particularly in those with microphthalmia and coloboma,10Gerth-Kahlert C. Williamson K. Ansari M. Rainger J.K. Hingst V. Zimmermann T. Tech S. Guthoff R.F. van Heyningen V. Fitzpatrick D.R. Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center.Mol. Genet. Genomic Med. 2013; 1: 15-31Crossref Scopus (66) Google Scholar, 11Chassaing N. Causse A. Vigouroux A. Delahaye A. Alessandri J.L. Boespflug-Tanguy O. Boute-Benejean O. Dollfus H. Duban-Bedu B. Gilbert-Dussardier B. et al.Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia.Clin. Genet. 2013; (Published online September 10, 2013)https://doi.org/10.1111/cge.12275Crossref Scopus (78) Google Scholar remains unknown. To further elucidate the genetic architecture of ocular coloboma, we performed exome sequencing on genomic DNA from an affected uncle and nephew (individuals II.6 and III.1) in a large family (family 1463) in which apparently isolated bilateral coloboma segregates in a pattern consistent with autosomal-dominant inheritance (Figure 1; Figure S3 and Table S2, available online). These were two of the 99 exome sequences (75 individuals with coloboma and 24 unaffected relatives from 58 different families) that comprised the coloboma contribution to the rare-diseases component of the UK10K project.12Williamson K.A. Rainger J. Floyd J.A. Ansari M. Meynert A. Aldridge K.V. Rainger J.K. Anderson C.A. Moore A.T. Hurles M.E. et al.UK10K ConsortiumHeterozygous loss-of-function mutations in YAP1 cause both isolated and syndromic optic fissure closure defects.Am. J. Hum. Genet. 2014; 94: 295-302Abstract Full Text Full Text PDF PubMed Scopus (80) Google Scholar This study was approved by the UK Multiregional Ethics Committee (reference 06/MRE00/76), and informed consent was obtained from all participating families. Exome sequencing was performed as previously described.13Olbrich H. Schmidts M. Werner C. Onoufriadis A. Loges N.T. Raidt J. Banki N.F. Shoemark A. Burgoyne T. Al Turki S. et al.UK10K ConsortiumRecessive HYDIN mutations cause primary ciliary dyskinesia without randomization of left-right body asymmetry.Am. J. Hum. Genet. 2012; 91: 672-684Abstract Full Text Full Text PDF PubMed Scopus (209) Google Scholar Sequences were aligned with the Burrows-Wheeler Aligner v.0.5.9, duplicates were marked with Picard v.1.43, realignment around indels and base quality scores were recalibrated with the Genome Analysis Toolkit (GATK) v.1.0.5506, and variants were called only with GATK Unified Genotyper. The coverage and depth metrics for these exomes and for each of the other exome analyses mentioned below are provided in Table S4. A total of 27 shared heterozygous, rare (maximum allele frequency < 0.005 and mutation count in UK10K coloboma exomes < 3) variants were identified (Table S1). Two frameshift and one in-frame deletion were called in IFT122 (MIM 606045) but were the result of misalignment of a single IFT122 heterozygous frameshift mutation causing autosomal-recessive cranioectodermal dysplasia (MIM 218330). All the remaining missense mutations or in-frame deletions affected different genes. Only one mutation (c.152G>A [p.Arg51His]; chr4: g.151504333G>A) was found to alter a gene (MAB21L2 [MIM 604357]) on our previously compiled list of 38 candidate genes for eye malformations (Table S3). This mutation is not reported in public databases, including the 1000 Genomes Project, the NHLBI Exome Sequencing Project (ESP) Exome Variant Server, and the Medical Research Council Human Genetics Unit in-house database of variants derived from ∼2,200 exomes. The RefSeq accession numbers NM_006439.4 and NP_006430.1 were used for naming this and all subsequent MAB21L2 variants at cDNA and protein levels, respectively. The entire UK10K coloboma exome data set is available from the European Genome-phenome Archive under a data-access agreement as study number EGAS00001000127. Independently, trio whole-exome sequencing of an affected Norwegian female (II.1 in family 676 [Figure 1]) with bilateral anophthalmia, macrocephaly, moderate intellectual disability, and generalized skeletal dysplasia (Table S2) and her parents was performed as previously described14Haugarvoll K. Johansson S. Tzoulis C. Haukanes B.I. Bredrup C. Neckelmann G. Boman H. Knappskog P.M. Bindoff L.A. MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing.Orphanet J. Rare Dis. 2013; 8: 1Crossref PubMed Scopus (36) Google Scholar as part of a study approved by the Regional Committee for Medical and Health Research Ethics in western Norway (institutional review board [IRB] 00001872; written informed consent was obtained from the family). A total of 217 rare variants (with a maximum allele frequency < 0.005 in 1000 Genomes and not present in 80 in-house-generated Norwegian exome samples from the same pipeline) were detected in the proband and filtered against parental exome data in a search for putative de novo variants. Using this approach, we detected four variants, of which only one (c.151C>T [p.Arg51Cys]; chr4: g.151504332C>T; in MAB21L2) was confirmed by Sanger sequencing. This de novo missense mutation was found to alter the same amino acid (Arg51) as that in family 1463. The substitution changes a strictly conserved residue, and both p.Arg51Cys and p.Arg51His are predicted to be deleterious by SIFT, PolyPhen2, and AlignGVGD. Subsequently, one of the authors identified an unrelated male individual (II.1 in family 4480) with more severe rhizomelic skeletal dysplasia associated with bilateral anophthalmia (Figure 1; Table S2). Analysis of DNA samples from this individual and his parents was performed as part of the study approved by the UK Multiregional Ethics Committee (reference 06/MRE00/76; informed consent was obtained from the family). Exactly the same mutation (c.151C>T [p.Arg51Cys]), which had also occurred de novo, was identified in the affected child. Microsatellite analysis of the DNA samples from each family was performed to confirm biological relationships and to exclude sample mix up. The de novo mutation c.151C>T (p.Arg51Cys) thus has a clinically recognizable phenotype. Resequencing of MAB21L2 was performed in 336 unrelated individuals with major eye malformations (and with no overlap with those who were exome sequenced) as part of the study approved by the UK Multiregional Ethics Committee (reference 06/MRE00/76; informed consent was obtained from all participating families). This analysis revealed one different ultra-rare (not present in the NHLBI ESP Exome Variant Server, 1000 Genomes, or UK10K variant databases) heterozygous missense mutation (Figure 1) in the simplex case of an adult male with bilateral colobomatous microphthalmia (individual II.1 in family 131 [Figure 1; Table S2]). This mutation (c.145G>A [p.Glu49Lys]; chr4: g.151504326G>A) affects the codon encoding a residue two amino acids N-terminal to the substitutions identified above (p.Arg51His and p.Arg51Cys). This man had a history of reasonably good vision until the age of 11 years, after which he became blind over a period of 2 years. He had no evidence of retinal detachment at the age of 30 years, and no retinal electrophysiology was available. He was of normal intelligence and had only minor skeletal dysmorphisms, recurrent dislocation of the patellae, and soft-tissue syndactyly of the third and fourth digits of his hands and of the second and third digits of both feet (Table S2). His mother was deceased, and therefore we were unable to confirm whether this mutation had occurred de novo in this man. A third independent exome sequencing study of distinct clinical phenotypes in children of consanguineous parents was carried out at the Baylor-Johns Hopkins Center for Mendelian Genomics under ethical approval from the Baylor College of Medicine (BCM) IRB (informed consent was obtained from all participating families). Two male siblings born to first-degree cousins were referred for clinical genetic assessment as a result of eye abnormalities. With the exception of subtle facial dysmorphic features and the eye findings, both boys had normal development. The elder boy (II.1 in family 4468) had left-eye esotropia in addition to a prominent forehead, periorbital fullness, long eyelashes, epicanthus, and a long and prominent philtrum (Table S2). Ophthalmologic examination revealed retinal coloboma including the optic disc and macula in the right eye, whereas there was sparing of the optic disc and macula in the left eye. Refractions were +2.0/+3.0 × 170 and −5.25/−3.25 × 115 in the right and left eyes, respectively. His younger brother (II.2 in family 4468) had right-eye exotropia and microphthalmia in addition to similar facial dysmorphic features. Ophthalmologic examination revealed bilateral retinal coloboma involving the optic disc in the right, but not the left, eye. Refractions were −2.00/−2.00 × 90 and +0.25/−1.50 × 175 in the right and left eyes, respectively. The parents of these siblings had normal vision and had no evidence of an asymptomatic structural eye malformation on ophthalmological examination. Whole-exome sequencing in both affected siblings identified a homozygous nonsynonymous substitution (c.740G>A [p.Arg247Gln]; chr4: g.151504921G>A, hg19; RefSeq NM_006439) in MAB21L2 in both brothers. This mutation has not been reported in public databases, including the 1000 Genomes Project, the NHLBI ESP Exome Variant Server, and the Atherosclerosis Risk in Communities Study database. In addition, this p.Arg247Gln substitution was not identified in an in-house-generated exome variant database from ∼2,500 individuals at the BCM Human Genome Sequencing Center and BCM Whole Genome Laboratory Database, which includes anonymized data from over 1,000 individuals tested for diagnostic purposes. Sanger sequencing was performed for segregation analysis, and the parents were found to be heterozygous carriers, consistent with Mendelian expectation. All experiments and analyses were performed according to previously described methods.15Bainbridge M.N. Hu H. Muzny D.M. Musante L. Lupski J.R. Graham B.H. Chen W. Gripp K.W. Jenny K. Wienker T.F. et al.De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome.Genome Med. 2013; 5: 11Crossref PubMed Scopus (113) Google Scholar The human gene is named after the ortholog in C. elegans. Mutations in Mab-21 cause posterior-to-anterior homeotic transformation of sensory ray 6 in the male tail in this worm.16Chow K.L. Hall D.H. Emmons S.W. The mab-21 gene of Caenorhabditis elegans encodes a novel protein required for choice of alternate cell fates.Development. 1995; 121: 3615-3626PubMed Google Scholar In normal development, Mab-21 has been shown to interact with Sin-3, a key component of a histone-deacetylase-containing transcriptional regulatory complex,17Choy S.W. Wong Y.M. Ho S.H. Chow K.L. C. elegans SIN-3 and its associated HDAC corepressor complex act as mediators of male sensory ray development.Biochem. Biophys. Res. Commun. 2007; 358: 802-807Crossref PubMed Scopus (27) Google Scholar and to be negatively regulated by CET-1 (whose human paralogs are BMP2, BMP4, and BMP7) signaling. After the identification of Mab-21 in C. elegans, multiple orthologous proteins were identified in human18Margolis R.L. Stine O.C. McInnis M.G. Ranen N.G. Rubinsztein D.C. Leggo J. Brando L.V. Kidwai A.S. Loev S.J. Breschel T.S. et al.cDNA cloning of a human homologue of the Caenorhabditis elegans cell fate-determining gene mab-21: expression, chromosomal localization and analysis of a highly polymorphic (CAG)n trinucleotide repeat.Hum. Mol. Genet. 1996; 5: 607-616Crossref PubMed Scopus (45) Google Scholar and mouse.19Mariani M. Corradi A. Baldessari D. Malgaretti N. Pozzoli O. Fesce R. Martinez S. Boncinelli E. Consalez G.G. Mab21, the mouse homolog of a C. elegans cell-fate specification gene, participates in cerebellar, midbrain and eye development.Mech. Dev. 1998; 79: 131-135Crossref PubMed Scopus (37) Google Scholar In zebrafish, expression of mab21l2 in the eye field is rx3 dependent. Morpholino knockdown of mab21l2 has been shown to produce a proliferation defect within the retinal progenitor cell population, resulting in small but structurally normal eyes.20Kennedy B.N. Stearns G.W. Smyth V.A. Ramamurthy V. van Eeden F. Ankoudinova I. Raible D. Hurley J.B. Brockerhoff S.E. Zebrafish rx3 and mab21l2 are required during eye morphogenesis.Dev. Biol. 2004; 270: 336-349Crossref PubMed Scopus (61) Google Scholar Analysis of the cis-regulatory elements surrounding mab21l2 has identified functionally significant subpopulations of cells within the developing eye,21Cederlund M.L. Vendrell V. Morrissey M.E. Yin J. Gaora P.Ó. Smyth V.A. Higgins D.G. Kennedy B.N. mab21l2 transgenics reveal novel expression patterns of mab21l1 and mab21l2, and conserved promoter regulation without sequence conservation.Dev. Dyn. 2011; 240: 745-754Crossref PubMed Scopus (12) Google Scholar although the role of the gene product in the formation or maintenance of these cells is not yet clear. Homozygous targeted inactivation of Mab21l2 in mouse embryos causes defects of the ventral body wall, severe eye malformations, and death in midgestation, whereas heterozygous null animals are apparently normal.22Yamada R. Mizutani-Koseki Y. Koseki H. Takahashi N. Requirement for Mab21l2 during development of murine retina and ventral body wall.Dev. Biol. 2004; 274: 295-307Crossref PubMed Scopus (63) Google Scholar Homozygous null embryos show failure of lens induction and aplasia of the retinal pigment epithelium as a result of a proliferation defect within the optic vesicle. Given the severity of the phenotype observed in the Mab21l2-null mouse embryos and the relatively mild phenotype in the siblings homozygous for c.740G>A (p.Arg247Gln), it seems likely that the human mutation does not result in complete loss of function. Although developmental expression of Mab21l2 in mouse embryos has been previously reported,23Wong R.L. Chan K.K. Chow K.L. Developmental expression of Mab21l2 during mouse embryogenesis.Mech. Dev. 1999; 87: 185-188Crossref PubMed Scopus (24) Google Scholar we wished to examine the expression in the developing eye in more detail. A digoxigenin-labeled antisense riboprobe targeted to the 5′ UTR of Mab21l2 (chr3: 86,547,729–86,548,237, mm10) was used for whole-mount in situ hybridization of 9.5, 10.5, 11.5, and 12.5 day postcoitum (dpc) mouse embryos (Figure S3). In addition to bright-field imaging, optical projection tomography (OPT) was also used for visualizing 10.5 dpc embryos as previously described.12Williamson K.A. Rainger J. Floyd J.A. Ansari M. Meynert A. Aldridge K.V. Rainger J.K. Anderson C.A. Moore A.T. Hurles M.E. et al.UK10K ConsortiumHeterozygous loss-of-function mutations in YAP1 cause both isolated and syndromic optic fissure closure defects.Am. J. Hum. Genet. 2014; 94: 295-302Abstract Full Text Full Text PDF PubMed Scopus (80) Google Scholar We chose 10.5 dpc for full descriptive analysis because this time point is prior to optic fissure closure but has a well-formed optic cup. Strong expression was evident in the rostral and distal regions of the developing neural retina (Figure 2A), and there was no expression immediately adjacent to the closing optic fissure (Figure 2B). Expression was also observed in the dorsal and ventral aspects of the developing forelimb bud and in the developing pharyngeal arches. The site- and stage-specific developmental expression pattern of Mab21l2 is thus compatible with the eye and limb phenotypic effects associated with the mutations we identified above. No Mab21l2 expression was observed in the brain at 10.5 dpc on OPT. However, imaging of more intensely stained embryos showed striking midbrain expression of Mab21l2 at 9.5 and 10.5 dpc (Figure S3). This might be important in view of the neurodevelopmental problems reported in the individuals (676 II.1 and 4480 II.1) carrying the substitution p.Arg51Cys. The highly localized distribution of the heterozygous missense mutations suggests a mutational mechanism that might not be simple loss of function. The biochemical function of MAB21L2 is not known, but the residues at which each of the amino acid substitutions occurred (Glu49, Arg51, and Arg247) in the human protein are completely conserved in mouse, zebrafish, and C. elegans (Figure S1). The family of 12 human Mab-21 paralogs adopt a nucleotidyltransferase fold24Kuchta K. Knizewski L. Wyrwicz L.S. Rychlewski L. Ginalski K. Comprehensive classification of nucleotidyltransferase fold proteins: identification of novel families and their representatives in human.Nucleic Acids Res. 2009; 37: 7701-7714Crossref PubMed Scopus (125) Google Scholar and include a cyclic GMP-AMP synthase (cGAS), which generates cyclic GMP-AMP in the cytoplasm of cells exposed to DNA.25Xiao T.S. Fitzgerald K.A. The cGAS-STING pathway for DNA sensing.Mol. Cell. 2013; 51: 135-139Abstract Full Text Full Text PDF PubMed Scopus (107) Google Scholar Detailed examination of the structure of both cGAS (Protein Data Bank [PDB] accession number 4K9B) and another family member, RNA-activated antiviral protein 2′-5′-oligoadenylate synthetase (OAS26Hartmann R. Justesen J. Sarkar S.N. Sen G.C. Yee V.C. Crystal structure of the 2′-specific and double-stranded RNA-activated interferon-induced antiviral protein 2′-5′-oligoadenylate synthetase.Mol. Cell. 2003; 12: 1173-1185Abstract Full Text Full Text PDF PubMed Scopus (132) Google Scholar [PDB 1PX5]), indicated conservation of the active site in MAB21L2 (Figure 3A). However, a sensitive colorimetric assay using purified MAB21L2 (from E. coli or human embryonic kidney 293 [HEK293] cells) with ATP as a substrate (Figure 3B) for analysis of pyrophosphate release27Meng H. Deo S. Xiong S. Dzananovic E. Donald L.J. van Dijk C.W. McKenna S.A. Regulation of the interferon-inducible 2′-5′-oligoadenylate synthetases by adenovirus VA(I) RNA.J. Mol. Biol. 2012; 422: 635-649Crossref PubMed Scopus (29) Google Scholar detected no nucleotidyltransferase activity, whereas OAS purified by the same methods resulted in strong activity. This analysis was repeated with a mixture of all nucleoside triphosphates (Figure S2) with different plausible activator molecules (double-stranded RNA or DNA and single-stranded RNA [ssRNA] or DNA [ssDNA]), but no enzymatic activity was detectable for MAB21L2. Enzymatic activation of OAS and cGAS occurs via conformational changes induced by binding with RNA and DNA, respectively.28Hartmann R. Norby P.L. Martensen P.M. Jorgensen P. James M.C. Jacobsen C. Moestrup S.K. Clemens M.J. Justesen J. Activation of 2′-5′ oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers.J. Biol. Chem. 1998; 273: 3236-3246Crossref PubMed Scopus (76) Google Scholar The structural comparisons suggested that a ∼35 Å long RNA- or DNA-binding groove also exists in MAB21L2 (Figure 3A; Figure S1). A fluorescent electromobility shift assay using Cy5- or Cy3-labeled ssRNA and ssDNA oligonucleotides and bacterially expressed protein showed binding of MAB21L2 to ssRNA, but not ssDNA (Figure 3C). To investigate the effect on ssRNA binding in each of the mutants (Figure 3D), we incubated a digoxigenin-labeled ssRNA (500 nt in length) in solution with sepharose-bead-bound wild-type or altered protein. After extensive washing, the binding of ssRNA to MAB21L2 was determined by fluorometry with an anti-digoxigenin-fluorescein antibody (Roche). Each of the four mutations, including the recessive mutation, resulted in loss of ssRNA-binding activity, consistent with the predicted locations of the affected residues close to the OAS RNA-binding cleft (Figure 3A). Complete loss of RNA binding in association with each of the mutations was remarkable but clearly cannot explain why the c.740G>A (p.Arg247Gln) variant is recessive and the other variants are dominant. We also had no knowledge of what the functional consequence of RNA binding was in the wild-type protein. We therefore created multiple independent stable tetracycline-inducible HEK293 cell lines expressing the wild-type MAB21L2 and each of the altered forms as full-length GFP-fusion proteins. We used this system first to accurately determine the stability of the induced proteins by using a timed pulse of tetracycline. These analyses showed that all three of the monoallelic mutations resulted in significant stabilization of the protein in comparison to either the wild-type protein or the p.Arg247Gln variant (Figures 4A and 4B ). Similar stabilization of altered protein has been reported in the recurrent de novo PACS1 mutations, associated with characteristic facial dysmorphisms and significant intellectual disability.29Schuurs-Hoeijmakers J.H. Oh E.C. Vissers L.E. Swinkels M.E. Gilissen C. Willemsen M.A. Holvoet M. Steehouwer M. Veltman J.A. de Vries B.B. et al.Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.Am. J. Hum. Genet. 2012; 91: 1122-1127Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar In this study, they observed cytoplasmic aggregates of altered GFP-tagged protein, but we could identify no obvious aggregation or localization differences in the MAB21L2 variants (Figure S4). No predicted ubiquitination site could be located in the vicinity of the MAB21L2 substitutions. However, failure of the altered proteins to be recognized by the ubiquitin-mediated degradation system is the most likely mechanism for this observation.30Bashir T. Pagano M. Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis.Adv. Cancer Res. 2003; 88: 101-144Crossref PubMed Scopus (74) Google Scholar Given the above-mentioned data from C. elegans, we used the inducible cell system to identify any MAB21L2-dependent alteration in SMAD family member 1, 5, and 8 (SMAD1/5/8) signaling or extracellular-signal-regulated kinase 1 and 2 (ERK1/2) signaling. Immunoblots using anti-phospho-SMAD1/5/8 antibodies detected no alteration in canonical BMP signaling between cells expressing tagged MAB21L2 and the same cells cultured without tetracycline (data not shown). However, induction of wild-type MAB21L2 consistently resulted in an ∼1.5-fold increase in 44 kDa phospho-ERK1 detected on immunoblot (Figures 4C and 4D). A similar level of induction was noted with the p.Arg51His substitution (Figures 4C and 4D). In mouse models of Noonan syndrome, an activating mutation in Ptpn11 has been expressed as a transgene with the use of different tissue-specific promoters. Expression in the developing heart31Nakamura T. C
Referência(s)